← Back to homepage
Astrazeneca share price tumbles as investors doubt merger with US rival
Sources
1
Coverage
Limited spectrum
Sentiment
0.00
◀ Left 0%Centre 100%Right 0% ▶
How we rate bias →This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.
NewsDeck Poll
Do you think this story is being covered fairly across the political spectrum?
Loading…
Left
(0)
No coverage from this perspective yet
Centre
(1)
City AM
Astrazeneca share price tumbles as investors doubt merger with US rival
Astrazeneca’s share price declined sharply in early trading after investors cast doubt over the potential merger with its US rival. The UK drugmaker’s shares suffered a six per cent decline in early trading to 11,866p, after reports it was exploring a possible $400bn megadeal with Bristol Myers Squibb. The FTSE 100 giant has been holding [...]
3 Aug, 09:56
Right
(0)
No coverage from this perspective yet